PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Feb-2022 AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers AstraZeneca
22-Feb-2022 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care sets climate targets: Climate neutrality by 2040, CO2 emissions to fall 50% by 2030 Fresenius Medical Care AG & Co. KGaA
22-Feb-2022 Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care delivers on 2021 guidance, targets return to earnings growth in 2022 Fresenius Medical Care AG & Co. KGaA
18-Feb-2022 DOUGLAS GMBH: DOUGLAS GMBH ANNOUNCES SYNDICATION OF €75 MILLION INCREMENTAL TERM LOAN B COMMITMENTS Douglas GmbH
17-Feb-2022 New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level Sciad Newswire
17-Feb-2022 Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini Heidelberg Pharma AG
17-Feb-2022 Douglas GmbH: DOUGLAS with significant sales and earnings growth in the first quarter 2021/22 Douglas GmbH
17-Feb-2022 PharmaSGP achieves record revenues in 2021 and exceeds analysts' expectations PharmaSGP Holding SE
17-Feb-2022 Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance Gerresheimer AG
17-Feb-2022 Moderna, Inc.: Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) Moderna, Inc.
16-Feb-2022 Biotest AG: Biotest exceeds Revenue guidance 2021 Biotest AG
16-Feb-2022 Two Million Euros for XO Life GmbH's Patient Insights Platform B3C newswire
16-Feb-2022 European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older Global Blood Therapeutics, Inc.
16-Feb-2022 atai Impact Donates to the Multidisciplinary Association for Psychedelic Studies (MAPS) to Support Pioneering Work in Psychedelic Medicine atai Life Sciences
16-Feb-2022 New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to enterprise-level Sciad Newswire
16-Feb-2022 Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus AstraZeneca
16-Feb-2022 Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus AstraZeneca
16-Feb-2022 European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults Pfizer
16-Feb-2022 Boyds boosts specialist clinical expertise with new hire Boyds
16-Feb-2022 Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform Curve Therapeutics